Genetic and clinical aspects of Brugada syndrome. An update.

Advances in Clinical Chemistry

Volumn 56, Issue , 2012, Pages 197-208

  Lippi, Giuseppe ^a   Montagnana, Martina ^b   Meschi, Tiziana ^c   Comelli, Ivan ^a   Cervellin, Gianfranco ^a  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c UNIVERSITY OF PARMA   (Italy)

Author keywords

Brugada syndrome; Genetics; Heart disease; Sudden cardiac death

Indexed keywords

EID: 84855308157     PISSN: 00652423     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-394317-0.00009-1     Document Type: Chapter

References (68)

1. Osher H.L., Wolff L. Electrocardiographic pattern simulating acute myocardial injury. Am. J. Med. Sci. 1953, 226:541-545.
2. Martini B., Nava A., Thiene G., et al. Ventricular fibrillation without apparent heart disease: description of six cases. Am. Heart J. 1989, 118:1203-1209.
3. Brugada P., Brugada J. A distinct clinical and echocardiographic syndrome: right bundle branch block, persistent ST segment elevation with normal QT interval and sudden cardiac death. Pacing Clin. Electrophysiol. 1991, 14:746-751.
4. Brugada P., Brugada J. Right bundle branch block, persistent ST segment elevation and sudden death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J. Am. Coll. Cardiol. 1992, 20:1391-1396.
5. Vatta M., Dumaine R., Varghese G., et al. Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome. Hum. Mol. Genet. 2002, 11:337-345.
6. Montagnana M., Lippi G., Franchini M., Targher G., Cesare Guidi G. Sudden cardiac death: prevalence, pathogenesis, and prevention. Ann. Med. 2008, 40:360-375.
7. Brugada P., Brugada R., Antzelevitch C., Nademanee K., Towbin J., Brugada J. The Brugada syndrome. Bridging Basic and Clinical Sciences 2003, 427-446. Human Press, Totowa, NJ. I. Gusaak, C. Antzelevicth (Eds.).
8. Antzelevitch C. Brugada syndrome. Pacing Clin. Electrophysiol. 2006, 9:1130-1159.
9. Rossenbacker T., Priori S.G. The Brugada syndrome. Curr. Opin. Cardiol. 2007, 22:163-170.
10. Viskin S. Brugada Syndrome in children: don't tell?. Circulation 2007, 115:1970-1972.
11. Frustaci A., Priori S.G., Pieroni M., et al. Cardiac histological substrate in patients with clinical phenotype of Brugada syndrome. Circulation 2005, 112:3680-3687.
12. Sidik N.P., Quay C.N., Loh F.C., Chen L.Y. Prevalence of Brugada sign and syndrome in patients presenting with arrhythmic symptoms at a Heart Rhythm Clinic in Singapore. Europace 2009, 11:650-656.
13. Patel S., Anees S., Ferrik K.J. Prevalence of a Brugada pattern electrocardiogram in an urban population in the United States. Pacing Clin. Electrophysiol. 2009, 32:704-708.
14. Antzelevitch C., Brugada P., Borggrefe M., et al. Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation 2005, 111:659-670.
15. Miyasaka Y., Tsuji H., Yamada K., et al. Prevalence and mortality of the Brugada-type electrocardiogram in one city in Japan. J. Am. Coll. Cardiol. 2001, 38:771-774.
16. Nademanee K., Veerakul G., Nimmannit S., et al. Arrhythmogenic marker for the sudden unexplained death syndrome in Thai men. Circulation 1997, 96:2595-2600.
17. Napolitano C., Priori S. Brugada sindrome. Orphanet J. Rare Dis. 2006, 1:35-40.
18. Brugada P., Brugada R., Antzelevitch C. The Brugada syndrome. Arch. Mal. Coeur Vaiss. 2005, 98:115-122.
19. Bezzina C.R., Shimizu W., Yang P., et al. Common sodium channel promoter haplotype in Asian subjects underlies variability in cardiac conduction. Circulation 2006, 113:338-344.
20. Klaver E.C., Versluijs G.M., Wilders R. Cardiac ion channel mutations in the sudden infant death syndrome. Int. J. Cardiol. 2011, 152:162-170.
21. Chen Q., Kirsch G.E., Zhang D., et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 1998, 392:293-296.
22. Brugada R., Brugada P., Brugada J., Hong K. Brugada syndrome. GeneReviews [Internet] 1993-2005, University of Washington, Seattle (WA), Mar 31 [updated 2009 Aug 11]. R.A. Pagon, T.D. Bird, C.R. Dolan, K. Stephens (Eds.).
23. Kapplinger J.D., Tester D.J., Alders M., et al. An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing. Heart Rhythm 2010, 7:33-46.
24. Capulzini L., Brugada P., Brugada J., Brugada R. Arrhythmia and right heart disease: from genetic basis to clinical practice. Rev. Esp. Cardiol. 2010, 63:963-983.
25. Koopmann T.T., Beekman L., Alders M., et al. Exclusion of multiple candidate genes and large genomic rearrangements in SCN5A in a Dutch Brugada syndrome cohort. Heart Rhythm 2007, 4:752-755.
26. Denjoy I., Extramiana F., Lupoglazoff J.M., Leenhardt A. Brugada syndrome. Presse Med. 2007, 36:1109-1116.
27. Ruan Y., Liu N., Priori S.G. Sodium channel mutations and arrhythmias. Nat. Rev. Cardiol. 2009, 6:337-348.
28. Watanabe H., Koopmann T.T., Le Scouarnec S., Yang T., Ingram C.R., Schott J.J. Sodium channel beta1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans. J. Clin. Invest. 2008, 118:2260-2268.
29. Valdivia C., Medeiros-Domingo A., Ye B., et al. Loss-of-function mutation of the SCN3B-encoded sodium channel {beta}3 subunit associated with a case of idiopathic ventricular fibrillation. Cardiovasc. Res. 2010, 1093:417-425.
30. Weiss R., Barmada M.M., Nguyen T., et al. Clinical and molecular heterogeneity in the Brugada syndrome: a novel gene locus on chromosome 3. Circulation 2002, 105:707-713.
31. Antzelevitch C. Genetic basis of Brugada syndrome. Heart Rhythm 2007, 4:756-757.
32. London B., Michale M., Mehdi H., et al. Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPDL-1) decreases cardiac Na-current and causes inherited arrhythmias. Circulation 2007, 116:2260-2268.
33. Antzelevitch C., Pollevick G.D., Cordeiro J.M., et al. Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation 2007, 115:442-449.
34. Cordeiro J.M., Marieb M., Pfeiffer R., Calloe K., Burashnikov E., Antzelevitch C. Accelerated inactivation of the L-type calcium due to a mutation in CACNB2b due to a mutation in CACNB2b underlies Brugada syndrome. J. Mol. Cell. Cardiol. 2009, 46:695-703.
35. Burashnikov E., Pfeiffer R., Barajas-Martinez H., et al. Mutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac death. Heart Rhythm 2010, 7:1872-1882.
36. Delpón E., Cordeiro J., Núñez L., et al. Functional effects of KCNE3 mutation and its role in the development of Brugada Syndrome. Circ. Arrhythm. Electrophysiol. 2008, 1:209-218.
37. Wu J., Shimizu W., Ding W.G., et al. KCNE2 modulation of Kv4.3 current and its potential role in fatal rhythm disorders. Heart Rhythm 2010, 7:199-205.
38. Abbott G.W., Sesti F., Splawski I., et al. MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Cell 1999, 97:175-187.
39. Ueda K., Hirano Y., Higashiuesato Y., et al. Role of HCN4 channel in preventing ventricular arrhythmia. J. Hum. Genet. 2009, 54:115-121.
40. Francis J., Antzelevitch C. Atrial fibrillation and Brugada syndrome. J. Am. Coll. Cardiol. 2008, 51:1149-1153.
41. Schulze-Bahr E., Eckardt L., Breithardt G., et al. Sodium channel gene (SCN5A) mutations in 44 index patients with Brugada syndrome: different incidences in familial and sporadic disease. Hum. Mutat. 2003, 21:651-652.
42. Ackerman M.J., Splawski I., Makielski J.C., et al. Spectrum and prevalence of cardiac sodium channel variants among black, white, Asian, and Hispanic individuals: implications for arrhythmogenic susceptibility and Brugada/long QT syndrome genetic testing. Heart Rhythm 2004, 1:600-607.
43. Viskin S., Rosso R. Risk of sudden death in asymptomatic Brugada syndrome: not as high as we thought and not as low as we wished...but the contrary. J. Am. Coll. Cardiol. 2010, 56:1585-1588.
44. Antzelevitch C., Brugada P., Brugada J., et al. Brugada syndrome: from cell to bedside. Curr. Probl. Cardiol. 2005, 30:9-54.
45. Wilde A.A., Antzelevitch C., Borggrefe M., et al. Proposed diagnostic criteria for the Brugada syndrome: consensus report. Circulation 2002, 106:2514-2519.
46. Shimizu W., Matsuo K., Kokubo Y., et al. Sex hormone and gender difference-role of testosterone on male predominance in Brugada syndrome. J. Cardiovasc. Electrophysiol. 2007, 18:415-421.
47. Amin A.S., Meregalli P.G., Bardai A., et al. Fever increases the risk for cardiac arrest in the Brugada syndrome. Ann. Intern. Med. 2008, 149:216-218.
48. Skinner J.R., Chung S.K., Nel C.A., et al. Brugada syndrome masquerading as febrile seizures. Pediatrics 2007, 119:1206-1211.
49. Mizumaki K., Fujiki A., Tsuneda T., et al. Vagal activity modulates spontaneous augmentation of ST elevation in the daily life of patients with Brugada syndrome. J. Cardiovasc. Electrophysiol. 2004, 5:667-673.
50. Matsuo K., Kurita T., Inagaki M., et al. The circadian pattern of the development of ventricular fibrillation in patients with Brugada syndrome. Eur. Heart J. 1999, 20:465-470.
51. Monroe M.H., Littman L. Two-year case collection of the Brugada syndrome electrocardiogram pattern at a large teaching hospital. Clin. Cardiol. 2000, 23:849-851.
52. Donohue D., Tehrani F., Jamehdor R., et al. The prevalence of Brugada ECG in adult patients in a large university hospital in the western United States. Am. Heart Hosp. J. 2008, 6:48-50.
53. Hong K., Brugada J., Oliva A., et al. Value of electrocardiographic parameters and ajmaline test in the diagnosis of Brugada syndrome caused by SCN5A mutations. Circulation 2004, 110:3023-3027.
54. Veltmann C., Wolpert C., Sacher F., et al. Response to intravenous ajmaline: a retrospective analysis of 677 ajmaline challenges. Europace 2009, 11:1345-1352.
55. Probst V., Veltmann C., Eckardt L., et al. Long-term prognosis of patients diagnosed with Brugada syndrome: results from the FINGER Brugada Syndrome Registry. Circulation 2010, 121:635-643.
56. Meregalli P.G., Wilde A.A., Tan H.L. Pathophysiological mechanisms of Brugada syndrome: depolarization disorder, repolarization disorder, or more?. Cardiovasc. Res. 2005, 67:367-378.
57. Kusano K.F., Taniyama M., Nakamura K., et al. Atrial fibrillation in patients with Brugada syndrome relationships of gene mutation, electrophysiology, and clinical backgrounds. J. Am. Coll. Cardiol. 2008, 51:1169-1175.
58. Bordachar P., Reuter S., Garrigue S., et al. Incidence, clinical implications and prognosis of atrial arrhythmias in Brugada syndrome. Eur. Heart J. 2004, 25:879-884.
59. Brugada P., Brugada R., Brugada J. Should patients with an asymptomatic Brugada electrocardiogram undergo pharmacological and electrophysiological testing?. Circulation 2005, 112:279-292.
60. Eckardt L., Kirchhof P., Schulze-Bahr E., et al. Electrophysiologic investigation in Brugada syndrome. Yield of programmed ventricular stimulation at two ventricular sites with up to three premature beats. Eur. Heart J. 2002, 23:1394-1401.
61. Epstein A.E., Di Marco J.P., Ellenbogen K.A., et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices). J. Am. Coll. Cardiol. 2008, 5:1-62.
62. Zipes D.P., Camm A.J., Borggrefe M., et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death-executive summary. A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J. Am. Coll. Cardiol. 2006, 48:1064-1108.
63. Priori S.G., Napolitano C., Gasparini M., et al. Natural history of Brugada syndrome: insights for risk stratification and management. Circulation 2002, 105:1342-1347.
64. Priori S.G., Napolitano C., Vicentini A. Inherited arrhythmia syndromes: applying the molecular biology and genetic to the clinical management. J. Interv. Card. Electrophysiol. 2003, 9:93-101.
65. Siniorakis E., Arvanitakis S., Prokovas E., Psatheris G., Exadactylos N. Brugada sign unmasking the location of an acute myocardial infarction. Kardiol. Pol. 2010, 68:708-710.
66. Lacunza J., San Román I., Moreno S., García-Molina E., Gimeno J., Valdés M. Heat stroke, an unusual trigger of Brugada electrocardiogram. Am. J. Emerg. Med. 2009, 27:634. e1-e3.
67. Kukla P., Jastrzebski M., Bacior B., Gomuła P., Grodecki J., Kawecka-Jaszcz K. Variant Brugada syndrome-mild ST segment elevation in inferior leads and aborted sudden cardiac death. Kardiol. Pol. 2007, 65:1494-1498.
68. Sovari A.A., Prasun M.A., Kocheril A.G. ST segment elevation on electrocardiogram: the electrocardiographic pattern of Brugada syndrome. MedGenMed 2007, 9:59.